Interrater Reliability of a Modified Bronchoscopy Scoring Tool in Children With Cystic Fibrosis

Alexandra Bosetti1, Srdjan Micic1, Andreas Hector1,2

  • 1Department of Respiratory Medicine, University Children's Hospital Zurich, Zürich, Switzerland.

Pediatric Pulmonology
|December 30, 2025
PubMed

Insights

A new scoring system for flexible bronchoscopy (FB) in children with Cystic Fibrosis (CF) shows good reliability for key CF-related airway features. This tool aids in assessing pediatric CF lung disease, though further validation is needed.

Area of Science:

  • Pulmonology
  • Pediatric Medicine
  • Medical Imaging

Background:

  • Flexible bronchoscopy (FB) is crucial for managing pediatric Cystic Fibrosis (CF) patients, aiding in visualizing airway issues, inflammation, and infections.
  • Existing scoring systems lack standardization for CF-specific airway inflammation assessment.

Purpose of the Study:

  • To modify and validate a pediatric bronchoscopy scoring tool for Cystic Fibrosis.
  • To enhance the assessment of airway inflammation in pediatric CF by incorporating CF-specific features.

Main Methods:

  • A pediatric bronchoscopy scoring tool was modified by adding four CF-relevant features: mucus plugging, secretion viscosity, bleeding, and vascular drawing.
  • Eighty bronchoscopy recordings (50 CF, 30 non-CF) were retrospectively scored by four blinded raters using ten visual features.
  • Inter-rater reliability was evaluated using Gwet's AC2 coefficient.

Main Results:

  • The modified score showed moderate to excellent inter-rater reliability for most features.
  • CF-specific features like mucus plugging (AC2=0.94) and bleeding (0.80) demonstrated high reliability.
  • Secretion viscosity (0.47) and vascular drawing (0.50) had lower inter-rater agreement, requiring further validation.

Conclusions:

  • The modified bronchoscopy scoring system offers a reliable method for assessing pediatric CF lung disease.
  • The inclusion of CF-specific features improves the assessment of airway inflammation.
  • Further validation is recommended for features with lower inter-rater reliability to optimize its clinical utility.
Abstract